Kratom Withdrawal: Case Report and Review of Epidemiology, Incidence, and Prevalence

Why it matters

Kratom withdrawal is increasingly encountered in clinical settings, yet clear epidemiological data on its frequency and presentation remain scarce. This case report contributes to the clinical literature needed to standardize treatment and build awareness among primary care providers.

The big picture

As kratom use has grown in the U.S., so have withdrawal presentations in emergency departments and addiction medicine clinics. While case reports and small reviews have described opioid-like withdrawal symptoms, large-scale studies are lacking. This new publication adds a case report alongside a review of available epidemiology, incidence, and prevalence data.

Key findings

• Kratom withdrawal syndrome resembles opioid withdrawal with symptoms including muscle aches, irritability, insomnia, nausea, and cravings
• Incidence is difficult to estimate because kratom alkaloids are not detected on standard immunoassay drug screens; chromatography-mass spectrometry is required
• Severity varies widely depending on dose, duration of use, and product type — with extract and 7-OH users showing more severe presentations
• Medication-assisted approaches including buprenorphine have been used successfully in some withdrawal cases
• The review identifies a need for standardized diagnostic criteria and validated screening tools specific to kratom withdrawal
• Large-scale population data to support formal epidemiological conclusions does not yet exist

What they say

The authors characterize kratom withdrawal as an "emerging clinical entity" requiring further empirical study to establish reliable diagnostic criteria and evidence-based treatment protocols.

Bottom line

**As kratom withdrawal cases increase in clinical settings, this review highlights the urgent need for standardized diagnostic tools and larger epidemiological studies to guide providers.**